Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Posterior Horn Cells | 2 | 2009 | 8 | 0.390 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2009 | 85 | 0.370 |
Why?
|
| Interneurons | 1 | 2009 | 94 | 0.300 |
Why?
|
| Nicotine | 2 | 2017 | 200 | 0.210 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2011 | 20 | 0.170 |
Why?
|
| Periaqueductal Gray | 1 | 2017 | 11 | 0.150 |
Why?
|
| Cholinergic Agents | 2 | 2017 | 17 | 0.150 |
Why?
|
| Foot Ulcer | 1 | 1996 | 3 | 0.140 |
Why?
|
| Metatarsal Bones | 1 | 1996 | 6 | 0.140 |
Why?
|
| Diabetic Foot | 1 | 1996 | 14 | 0.140 |
Why?
|
| Nicotinic Agonists | 1 | 2017 | 74 | 0.140 |
Why?
|
| Medulla Oblongata | 1 | 2017 | 93 | 0.140 |
Why?
|
| Receptors, Nicotinic | 2 | 2017 | 131 | 0.140 |
Why?
|
| Analgesics | 2 | 2017 | 119 | 0.130 |
Why?
|
| Spinal Cord | 2 | 2009 | 255 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2017 | 319 | 0.130 |
Why?
|
| Serotonergic Neurons | 1 | 2011 | 4 | 0.100 |
Why?
|
| Raphe Nuclei | 1 | 2011 | 37 | 0.090 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 88 | 0.090 |
Why?
|
| Neural Inhibition | 2 | 2009 | 97 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 2 | 2009 | 397 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2009 | 365 | 0.090 |
Why?
|
| Nucleus Accumbens | 1 | 2011 | 113 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2009 | 524 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 996 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 31 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2009 | 32 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 124 | 0.080 |
Why?
|
| Lysine | 1 | 2009 | 152 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 309 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 899 | 0.070 |
Why?
|
| Age Factors | 2 | 2009 | 1880 | 0.070 |
Why?
|
| Receptors, Presynaptic | 1 | 2006 | 4 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 1996 | 2316 | 0.070 |
Why?
|
| Glycine | 1 | 2006 | 96 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 66 | 0.060 |
Why?
|
| Action Potentials | 1 | 2009 | 601 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1579 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 1237 | 0.050 |
Why?
|
| Rats | 3 | 2017 | 4048 | 0.050 |
Why?
|
| Animals | 5 | 2017 | 27536 | 0.050 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2017 | 22 | 0.040 |
Why?
|
| Quinuclidines | 1 | 2017 | 26 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2017 | 45 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2017 | 177 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2017 | 92 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1983 | 0.030 |
Why?
|
| Bone Regeneration | 1 | 1996 | 62 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 228 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 335 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1996 | 171 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 11858 | 0.030 |
Why?
|
| Recurrence | 1 | 1996 | 1147 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 451 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 135 | 0.020 |
Why?
|
| Pain | 1 | 2013 | 400 | 0.020 |
Why?
|
| Male | 3 | 2017 | 42705 | 0.020 |
Why?
|
| Cadmium Chloride | 1 | 2006 | 12 | 0.020 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Kainic Acid | 1 | 2006 | 22 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 121 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2006 | 69 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 244 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1996 | 9237 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1929 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1179 | 0.010 |
Why?
|
| Humans | 2 | 2013 | 90014 | 0.010 |
Why?
|
| Female | 1 | 1996 | 46617 | 0.010 |
Why?
|